Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AstraZeneca: Shares Drop Amidst Reports of PRC Investigation

December 24, 2024
AstraZeneca PLC, a leading pharmaceutical company, saw a decline in its shares following reports of a probe initiated by the People's Republic of China (PRC). The investigation revolves around alleged fraud and corruption within the company. As a result, the shares of AstraZeneca (AZN) fell significantly in the stock market. Investors are closely watching the developments of this situation, which could have potential repercussions on the company's reputation and financial performance. For expert insights on the future movement of AstraZeneca's shares, it is recommended to consult professionals from Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNJune 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know  ~1 min.

AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....


AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....


AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....


AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....


AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....


AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....


AZNMarch 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy  ~2 min.

ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....


AZNFebruary 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential  ~2 min.

AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....


AZNFebruary 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....


AZNFebruary 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....


AZNDecember 14, 2024Hagens Berman Alleges Fraud and Corruption in AstraZeneca AZN; Shares Plummet  ~1 min.

Leading law firm Hagens Berman has initiated an investigation into British pharmaceutical giant AstraZeneca PLC (NASDAQ:AZN) following reports of potential fraud and corruption within the company....


AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....


AZNDecember 26, 2024AstraZeneca Faces Investigation in China; Shares Plummet  ~2 min.

AstraZeneca PLC (AZN) shares dropped significantly today following reports of a probe by the People's Republic of China (PRC) into alleged fraud and corruption within the company....


AZNOctober 30, 2024Astrazeneca AZN Declines More Than Market: Some Information for Investors  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has experienced a decline in its stock value, performing worse than the overall market....


AZNJanuary 1, 2025New breakthrough in medical research announced by AstraZeneca PLC AZN  ~2 min.

Leading pharmaceutical company AstraZeneca PLC AZN has made a groundbreaking discovery in the field of medical research....